Expression of inflammasome-related genes in bladder cancer and their association with cytokeratin 20 messenger RNA

作者: Giulia Poli , Stefano Brancorsini , Giovanni Cochetti , Francesco Barillaro , Maria Giulia Egidi

DOI: 10.1016/J.UROLONC.2015.07.012

关键词:

摘要: Abstract Background Inflammation plays a crucial role in different stages of cancer development and has long been associated with various types cancer. Strong associations between dysregulated inflammasome activity human heritable acquired inflammatory diseases highlight the importance this pathway immune response. The is large complex NOD-like receptors called NLRs drives growth progression tumors. aim present study was characterization some NLR genes, NLRP3, NLRP4, NLRP9, NAIP, urine sediment patients bladder Cytokeratin 20 survivin were used as confirmed markers Basic procedures For study, 3 groups subjects considered: harboring cancer, affected by inflammation (CTR1), healthy (CTR0). Total RNA extracted from sediments resulting complementary DNA for amplification real-time polymerase chain reaction. Results stratified according to tumor stage, grade, risk recurrence. Main findings expression cytokeratin always significantly higher when compared that both tumor-free groups. NAIP overexpressed BCa CTR0. Stratification recurrence showed NLRP up-regulations early-stage high-risk comparison CTR0 high-grade CTR1. Principal conclusions These data are relevant demonstrate urothelial carcinoma, making genes potential candidates diagnosis.

参考文章(31)
P Harnden, L K Trejdosiewicz, J Southgate, Cytokeratin expression patterns in normal and malignant urothelium: a review of the biological and diagnostic implications. Histology and Histopathology. ,vol. 14, pp. 657- 664 ,(1999) , 10.14670/HH-14.657
Peter J. Olbert, Claudia Kesch, Marcus Henrici, Florentine S. Subtil, Astrid Honacker, Axel Hegele, Rainer Hofmann, Jörg Hänze, TLR4- and TLR9-dependent effects on cytokines, cell viability, and invasion in human bladder cancer cells Urologic Oncology-seminars and Original Investigations. ,vol. 33, ,(2015) , 10.1016/J.UROLONC.2014.09.016
Paolo Boffetta, Fei Ye, Matthew D Galsky, Russell McBride, David Y Zhang, Mireia Castillo-Martin, Jun Zhu, Carlos Cordon-Cardo, Li Wang, Biomarkers for bladder cancer management: present and future. American journal of clinical and experimental urology. ,vol. 2, pp. 1- 14 ,(2014)
W. W. Franke, J. Laufer, R. Moll, A. Löwe, Cytokeratin 20 in human carcinomas. A new histodiagnostic marker detected by monoclonal antibodies. American Journal of Pathology. ,vol. 140, pp. 427- 447 ,(1992)
Gregory T MacLennan, Ziya Kirkali, Liang Cheng, None, Histologic Grading of Noninvasive Papillary Urothelial Neoplasms European Urology. ,vol. 51, pp. 889- 898 ,(2007) , 10.1016/J.EURURO.2006.10.037
Catharina Hagerling, Amy-Jo Casbon, Zena Werb, Balancing the innate immune system in tumor development Trends in Cell Biology. ,vol. 25, pp. 214- 220 ,(2015) , 10.1016/J.TCB.2014.11.001
XIAOCHI CHEN, TIEZHENG WANG, DEYONG YANG, JIANBO WANG, XIANCHENG LI, ZHONGZHOU HE, FENG CHEN, XIANGYU CHE, XISHUANG SONG, Expression of the IAP protein family acts cooperatively to predict prognosis in human bladder cancer patients Oncology Letters. ,vol. 5, pp. 1278- 1284 ,(2013) , 10.3892/OL.2013.1150
Isil Z Yildiz, Rosemary Recavarren, Henry B Armah, Sheldon Bastacky, Rajiv Dhir, Anil V Parwani, Utility of a dual immunostain cocktail comprising of p53 and CK20 to aid in the diagnosis of non-neoplastic and neoplastic bladder biopsies Diagnostic Pathology. ,vol. 4, pp. 35- 35 ,(2009) , 10.1186/1746-1596-4-35
Laurence Zitvogel, Oliver Kepp, Lorenzo Galluzzi, Guido Kroemer, Inflammasomes in carcinogenesis and anticancer immune responses Nature Immunology. ,vol. 13, pp. 343- 351 ,(2012) , 10.1038/NI.2224
Jorge Henao-Mejia, Eran Elinav, Till Strowig, Richard A Flavell, Inflammasomes: far beyond inflammation. Nature Immunology. ,vol. 13, pp. 321- 324 ,(2012) , 10.1038/NI.2257